The IT Nerd

Global visual technologies company Christie® is pleased to introduce its newest CE- and UL- certified commercial UVC-LED disinfection light fixture for occupied, indoor spaces. Christie CounterAct™ UR10 with UVC-LED and patented Care222® far-UVC – plus visible light, in a single unit, is recommended for commercial offices, government facilities, schools, transit hubs, retail shops, medical buildings — for enhanced and safe airborne and surface disinfection wherever people gather indoors, in public places.

CounterAct UR10 builds on the release of the CA20, Christie’s first far-UVC disinfection fixture, and the desire among global business and government leaders to increase confidence and improve wellbeing in our indoor spaces, such as meeting rooms, classrooms, and other places people gather. Combining filtered Care222® far-UVC light with upper room high-power mercury-free UVC-LED, CounterAct UR10 is an evolution in technology for treating both surfaces and air in occupied indoor spaces.

The new reality is that on average we’re seeing a pandemic arise every four years since the year 2000¹. This trend indicates the 2023 common cold, flu season and the next pandemic are right around the corner. This is why the U.S. government is committing, through the American Rescue Plan, a total of USD$472 billion² for schools as well as state, local, and tribal governments which can be used to deploy systems such as CounterAct UR10 UVC disinfection light fixtures.

CounterAct UR10, which kills both airborne and surface pathogens, can be installed in rooms with ceiling heights between 9 and 22 feet (3-7.6m), includes remote control features with iOS and Android support, and can be integrated with building automation/management systems. Peckover explains, “UVC disinfection systems should be seamless and require no day-to-day user interaction while effectively inactivating pathogens in the occupied space.”

As we prepare for a post-pandemic world where reducing pathogens and viral spread is essential, global visual technology company Christie®announced the mass production of its Christie® CounterAct™ line of commercial UV disinfection products with patented Care222® far-UVC light technology. CounterAct fixtures are designed for use in occupied indoor spaces, from cinemas, theme parks, museums, and sports complexes, to retail, restaurants, as well as transit hubs at airports, train and subway stations.

Developed by Christie, and using parent company Ushio Inc.’s Care222nm UV lamp technology that’s licensed through Columbia University, the CounterAct line of mounted fixtures is designed for high-ceiling applications, which are as easy to install as commercial lighting fixtures. 

The first UV disinfection technology developed for use around people, Christie CounterAct uses proprietary filtered far-UVC light to eliminate 99% of pathogens on surfaces in indoor spaces, including the SARS-CoV-2 coronavirus that causes COVID-19, influenza, bacteria, and other antibiotic-resistant superbugs by damaging the DNA or RNA of the pathogen, which leaves them unable to reproduce and infect humans.

To date, Christie CounterAct models have demonstrated compliance with UL, CE and UKCA by third-party testing facilities for electrical safety, electromagnetic compatibility (EMC), compliance with the radio equipment directive, and most importantly photobiological safety. 

Photobiological compliance is a safety evaluation to confirm that the level of UV exposure for occupants is in line with accepted industry guidelines – a critical component of the third-party testing. 

Advancements in technology have made UV disinfection safer and more effective 

UV light has long been proven to effectively neutralize pathogens, but the 254nm wavelength used in other disinfection products on the market is a human health hazard because it can penetrate and damage human eyes and skin, making it unsafe for human exposure.

Award-winning CounterAct fixtures contain Ushio’s patented Care222 lamps that emit far-UVC 222nm light – which was shown in a 2020 study by Kobe University to be safely used with people present, making it a sweet spot on the UV spectrum that’s effective against pathogens in occupied spaces. Additionally, Care222 is the world’s first far-UVC technology with a proprietary optical filter that blocks potentially harmful longer (>230nm) UVC wavelengths from being emitted. 

 For more information visit Christie’s CounterAct website.

Lennox Lewis, professional boxing’s last undisputed world heavyweight champion, has taken ownership of a Christie Boxer 4K30 projector.

“Mike Garrido, Senior Product Manager, Christie (Left) passes the remote for a new Christie Boxer 4K30 on to  Lennox Lewis, Undisputed World Heavyweight Champion”

The Christie Boxer 4K30 made its worldwide debut in January 2015 at the Integrated Systems Europe (ISE) show in Amsterdam, Netherlands and Lewis attended the pre-launch festivities in November 2014 at Christie’s worldwide center of engineering excellence. A global hit, Boxer 4K30 delivers, pound for pound, the ultimate combination of power, brightness, performance and durability.

Combining the most lumens, the most pixels, and 3DLP quality, the award winning Christie Boxer is the smallest, lightest, yet most rugged design available in its class. The first offering from the new Boxer Series, the Boxer 4K30 was quickly embraced for rental staging and fixed installation applications including concerts, amusement parks, projection mapping projects, museums, planetariums and more.